HEMATIDE
Dead / Abandoned — Abandoned — no statement of use filed (as of 23 Sept 2013)
What this means for you
This application is over — abandoned 23 Sept 2013. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85383694
- Mark type
- Stylized text
- Filed
- 28 Jul 2011
- Published for opposition
- 27 Dec 2011
- Abandoned
- 23 Sept 2013
- Attorney of record
- Anne Peck
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke
Owner
- Affymax, Inc., Palo Alto, CA, US
- Affymax, Inc., Palo Alto, CA, US
Prosecution history
- 11 Oct 2013 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Sept 2013 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 23 Sept 2013 — ABANDONMENT - NO USE STATEMENT FILED
- 23 Feb 2013 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Feb 2013 — SOU EXTENSION 2 GRANTED
- 12 Feb 2013 — SOU EXTENSION 2 FILED
- 21 Feb 2013 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Feb 2013 — SOU TEAS EXTENSION RECEIVED
- 20 Jun 2012 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jun 2012 — SOU EXTENSION 1 GRANTED
- 18 Jun 2012 — SOU EXTENSION 1 FILED
- 18 Jun 2012 — SOU TEAS EXTENSION RECEIVED
- 21 Feb 2012 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Dec 2011 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Dec 2011 — PUBLISHED FOR OPPOSITION